Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma

Overview of attention for article published in Blood, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 57,286 followers.

RT @BloodJournal: Targeting glycogen synthase kinase 3 for therapeutic benefit in #lymphoma https://t.co/JfqpOjQqVw https://t.co/5cdkB61T33

Targeting glycogen synthase kinase 3 for therapeutic benefit in #lymphoma https://t.co/JfqpOjQqVw https://t.co/5cdkB61T33

Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma. https://t.co/ZvH5PUuQCT

Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma. #lymphoma #lymsm https://t.co/dd2gZmvqpr

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.